Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
PSA
2 other identifiers
interventional
1,006
1 country
1
Brief Summary
The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening. The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge. The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county. Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview. The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable prostate-cancer
Started Apr 2003
Longer than P75 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 26, 2008
CompletedFirst Posted
Study publicly available on registry
September 29, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedMarch 7, 2025
March 1, 2025
22.9 years
September 26, 2008
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inform Decision-Making
6 months post-baseline interview
Secondary Outcomes (1)
Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers
6 months post-baseline interview
Study Arms (2)
1
EXPERIMENTALEducational small group session regarding prostate cancer
2
OTHERPrinted material regarding general prostate cancer information provided.
Interventions
A one-hour discussion group composed of 8-10 Latino men. The session includes an interactive, multimedia presentation led by a facilitator to guide participant interaction.
Eligibility Criteria
You may qualify if:
- Latino men
- to 70 years old
- Not ever having prostate biopsy
- Not ever having prostate cancer
- Not having had a PSA test within the past 12 months
- Not having BPH (prostate inflammation)
- Not currently experiencing prostate problems such as pain or burning sensation during urination, blood in urine, and/or desire to urinate frequently
You may not qualify if:
- Not Latino
- Younger than 50 or older than 70 years old
- Currently experiencing prostate problems such as pain or burning sensations while urinating, blood in urine, and/or desire to urinate frequently
- Living outside of Los Angeles county
- Having had a prostate biopsy
- Having had prostate cancer previously
- Having had a prostatectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA, Division of Cancer Prevention and Control Research
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roshan Bastani, PhD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2008
First Posted
September 29, 2008
Study Start
April 1, 2003
Primary Completion
February 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
March 7, 2025
Record last verified: 2025-03